Aminopolyther used to dissolve K+ salts in nucleophilic [18F] labelling reactions.
Packaged in amber vial or amber screw cap vials with teflon-coated stoppers under argon atmosphere.
Store the product in normal temperature and protected from light. Short term storage at higher temperatures does not affect product quality.
222-99-0020x 20mg per vial 222-99-0100x 100mg per vial 222-99-0250x 250mg per vial 222-99-1000x 1g per vial note: x includes A B C and D, A refers to 2ml vial; B refers to 4.5ml vial; C refers to 8ml vial; D refers to 30ml vial *Customized dispensing is available
Huang J.C. Comparison of Various Requirements of the Quality Assurance Procedures for 18F-FDG Injection. J. Nucl. Med. 2002, 43, 1495-1506.
Lemaire C. et al. No-carrier-added regioselective preparation of 6-[18F]fluoro-L-DOPA. J.
Nucl. Med. 1990,31,1247-51.
Moerlein S. et al. Elimination of contaminant Kryptofix 2.2.2 in the routine production of
2-[18F]fluoro-2-deoxy-D-Dglucose.Int. J. Rad. Appl. Instrum. [A] 1989, 40, 741-3.
Chaly T. et al. Thin layer chromatographic detection of Kryptofix 222 in the routine synthesis
of [18F]2-fluoro-2-deoxy-D-glucose. Int. J. Rad. Appl. Instrum. [B] 1989, 16, 385-7.